Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3006358rdf:typepubmed:Citationlld:pubmed
pubmed-article:3006358lifeskim:mentionsumls-concept:C0021051lld:lifeskim
pubmed-article:3006358lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3006358lifeskim:mentionsumls-concept:C0002199lld:lifeskim
pubmed-article:3006358lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:3006358lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:3006358pubmed:issue6lld:pubmed
pubmed-article:3006358pubmed:dateCreated1986-3-31lld:pubmed
pubmed-article:3006358pubmed:abstractTextThe capacity of leukocytes from children with primary immunodeficiency to produce alpha- and gamma-interferons in vitro was studied. Interferon response of leukocytes in most of the patients examined was found to be practically unchanged. The immunostimulating therapy in some cases exerted a regulating effect on leukocyte capacity for interferon production. It is assumed that the interferon-producing function of T lymphocytes may be preserved in patients suffering from primary immunodeficiency.lld:pubmed
pubmed-article:3006358pubmed:languageruslld:pubmed
pubmed-article:3006358pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3006358pubmed:citationSubsetIMlld:pubmed
pubmed-article:3006358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3006358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3006358pubmed:statusMEDLINElld:pubmed
pubmed-article:3006358pubmed:issn0507-4088lld:pubmed
pubmed-article:3006358pubmed:authorpubmed-author:BabaiantsA...lld:pubmed
pubmed-article:3006358pubmed:authorpubmed-author:ManakhovaL...lld:pubmed
pubmed-article:3006358pubmed:authorpubmed-author:KarganovaG...lld:pubmed
pubmed-article:3006358pubmed:authorpubmed-author:Porkhovaty?S...lld:pubmed
pubmed-article:3006358pubmed:authorpubmed-author:KondratenkoI...lld:pubmed
pubmed-article:3006358pubmed:issnTypePrintlld:pubmed
pubmed-article:3006358pubmed:volume30lld:pubmed
pubmed-article:3006358pubmed:ownerNLMlld:pubmed
pubmed-article:3006358pubmed:authorsCompleteYlld:pubmed
pubmed-article:3006358pubmed:pagination714-7lld:pubmed
pubmed-article:3006358pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:meshHeadingpubmed-meshheading:3006358-...lld:pubmed
pubmed-article:3006358pubmed:articleTitle[Leukocyte interferon reaction in patients with primary immunodeficiencies].lld:pubmed
pubmed-article:3006358pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3006358pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3006358pubmed:publicationTypeEnglish Abstractlld:pubmed